HWM
HRMY icon

Hemington Wealth Management’s Harmony Biosciences HRMY Stock Holding History

Hemington Wealth Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$0 Sell
27
-1
-4% -$34 ﹤0.01% 1619
2025
Q2 		$0 Buy
28
+14
+100% +$450 ﹤0.01% 1599
2025
Q1 		$0 Buy
14
+4
+40% +$143 ﹤0.01% 1609
2024
Q4 		$0 Buy
10
+2
+25% +$69 ﹤0.01% 1647
2024
Q3 		$0 Buy
+8
New +$281 ﹤0.01% 1599

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $86.2B AUM 12.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hemington Wealth Management's HRMY Position: Q3 2025 in Review

Hemington Wealth Management reduced its Harmony Biosciences (HRMY) stake by 3.6% in Q3 2025, selling an estimated $34 and leaving 27 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Hemington Wealth Management first reported a position in HRMY in Q3 2024 and has held it in 5 quarters since. 296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

  • Hemington Wealth Management held 27 shares of Harmony Biosciences worth $0 as of Q3 2025.
  • Hemington Wealth Management sold 1 Harmony Biosciences share in Q3 2025, an estimated $34.
  • Harmony Biosciences made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1619 holding.
  • Hemington Wealth Management first reported a position in Harmony Biosciences in Q3 2024 and has held it in 5 quarters since.
  • 296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.